Clinical Topics
November 16, 2023
T2D: Real benefits of new oral antidiabetic drugs
November 16, 2023
MDedge Endocrinology
November 14, 2023
Blood test could predict future disability in MS
November 14, 2023
MDedge Neurology
November 1, 2023
Semaglutide prescribing surged in the past year
November 1, 2023
MDedge Endocrinology
October 31, 2023
Nirmatrelvir-ritonavir ineffective at reducing most post-COVID conditions
October 31, 2023
MDedge Internal Medicine
October 19, 2023
Antidepressants ‘don’t blunt’ semaglutide and weight loss
October 19, 2023
Obesity Week
MDedge Endocrinology
October 19, 2023
Taking a new obesity drug and birth control pills? Be careful
October 19, 2023
MDedge ObGyn
September 22, 2023
FDA panel rejects implanted GLP1-RA dosing device for T2D
September 22, 2023
MDedge Endocrinology
September 21, 2023
Exercise timing may dictate obesity, type 2 diabetes risk
September 21, 2023
MDedge Endocrinology